764274008: Ertugliflozin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Ertugliflozin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Ertugliflozin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Diphenylmethane\Ertugliflozin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3647251017 Ertugliflozin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3647252012 Ertugliflozin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

51811000195113 ertugliflozin it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

854671000241117 ertugliflozine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

66081000195114 Ertugliflozin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ertugliflozin	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Some
Ertugliflozin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Some
Ertugliflozin	Is a	Diphenylmethane	true	Inferred relationship	Some
Ertugliflozin	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing ertugliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	1
Product containing ertugliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	1
Product containing only ertugliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	1
Product containing only ertugliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	1
Ertugliflozin pidolate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Ertugliflozin	Inferred relationship	Some
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ertugliflozin	Inferred relationship	Some	1
Ertugliflozin (as ertugliflozin pidolate) 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ertugliflozin	Inferred relationship	Some	1
Allergy to ertugliflozin	Causative agent (attribute)	True	Ertugliflozin	Inferred relationship	Some	1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ertugliflozin	Inferred relationship	Some	2
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ertugliflozin	Inferred relationship	Some	2
Product containing only ertugliflozin and sitagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	2
Ertugliflozin- and sitagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	2
Ertugliflozin- and sitagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	2
Product containing only ertugliflozin and sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ertugliflozin	Inferred relationship	Some	2

This concept is not in any reference sets